Showing results (11-20 of 15) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Neuropharmacology|August 1, 1986
The effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal and limbic catecholamine neurones in white and black mice. Antagonism by monoamine oxidase inhibitorsA J Bradbury, B Costall, P G Jenner, et al.Neuroscience Letters|October 24, 1985
The toxic actions of MPTP and its metabolite MPP+ are not mimicked by analogues of MPTP lacking an N-methyl moietyA J Bradbury, B Costall, A M Domeney, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1989
Antiparkinsonian activity of CY 208-243, a partial D-1 dopamine receptor agonist, in MPTP-treated marmosets and patients with Parkinson's diseaseJ A Temlett, N P Quinn, P G Jenner, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 4, 2010
An in vivo pharmacological evaluation of pardoprunox (SLV308)--a novel combined dopamine D(2)/D(3) receptor partial agonist and 5-HT(1A) receptor agonist with efficacy in experimental models of Parkinson's diseaseC A Jones, L C Johnston, M J Jackson, et al.Annals of Neurology|March 1, 1994
Nigrostriatal function in vitamin E deficiency: clinical, experimental, and positron emission tomographic studiesD T Dexter, D J Brooks, A E Harding, et al.Pageof 2